<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://mavengity.com/articles/finance/softbank-ai-data-center-writedown-quarterly-loss/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T19:47:32+00:00</news:publication_date>
      <news:title>SoftBank Takes a $7 Billion Loss as AI Data Center Costs Bite</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/finance/senate-energy-permitting-bill-data-center-grid-costs/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T16:47:29+00:00</news:publication_date>
      <news:title>Senate Advances Energy Permitting Bill as Data Centers Pick Up Grid Costs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/finance/fincen-mexc-special-measure-crypto-exchange/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T15:47:58+00:00</news:publication_date>
      <news:title>Treasury Cuts MEXC Off From the U.S. Financial System</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/mirum-brelovitug-hepatitis-delta-azure-4/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T14:48:12+00:00</news:publication_date>
      <news:title>Mirum&apos;s Hepatitis Delta Antibody Clears a Second Phase 3 Trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/cms-rural-health-transformation-awards-missed-deadline/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T13:48:19+00:00</news:publication_date>
      <news:title>CMS Releases $10 Billion in Rural Health Awards Without Explaining the Delay</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/finance/anthropic-ipo-fable-mythos-5-2-model-launch/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-10T08:47:59+00:00</news:publication_date>
      <news:title>Anthropic Ships Faster, Cheaper Models Into Its IPO Window</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/legal/ninth-circuit-california-climate-disclosure-sb253-sb261/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T23:47:27+00:00</news:publication_date>
      <news:title>The Ninth Circuit Splits California&apos;s Climate Disclosure Laws</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/sunharbo-asundexian-factor-xia-stroke-approval/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T22:47:01+00:00</news:publication_date>
      <news:title>A New Stroke Drug Class Starts With a Narrow Approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/fda-glp1-naion-vision-loss-warning/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T19:46:36+00:00</news:publication_date>
      <news:title>A Rare Eye Risk Joins the GLP-1 Label</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/finance/unicredit-commerzbank-control-board-overhaul/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T16:47:52+00:00</news:publication_date>
      <news:title>UniCredit Moves From Stake to Control at Commerzbank</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/cms-drug-price-negotiation-final-rule-2029/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T15:49:14+00:00</news:publication_date>
      <news:title>Medicare&apos;s Drug Price Negotiation Program Gets a Permanent Rulebook</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/legal/roybal-griffith-transgender-prison-gvr/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T14:52:13+00:00</news:publication_date>
      <news:title>The Supreme Court Sends a Transgender Prison Case Back Down</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/vir-hepatitis-delta-eclipse-1-functional-cure/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T14:48:00+00:00</news:publication_date>
      <news:title>The First Hepatitis Delta Drug Has a Challenger</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/legal/supreme-court-bivens-pipeline-fees-arguments/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T13:48:22+00:00</news:publication_date>
      <news:title>The Supreme Court Hears Two Cases About the Courthouse Door</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/anktiva-bcg-naive-nmibc-first-line/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T12:47:33+00:00</news:publication_date>
      <news:title>A Second-Line Bladder Cancer Drug Tries for the Front of the Line</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/healthcare-medical/cvs-health-pharmacy-split-conglomerate/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T10:52:33+00:00</news:publication_date>
      <news:title>CVS Splits Itself in Two, and the Market Asks What Comes Next</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://mavengity.com/articles/finance/single-stock-perpetual-futures-cftc-court-fight/</loc>
    <news:news>
      <news:publication>
        <news:name>Mavengity</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-09T10:52:27+00:00</news:publication_date>
      <news:title>Single-Stock Perpetuals Land in the U.S. With a Court Fight Attached</news:title>
    </news:news>
  </url>
</urlset>
